Brickell Biotech Company
Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
Technology:
Biotechnology, Health Care, Therapeutics
Industry:
End-to-end Drug Development
Headquarters:
Miami, Florida, United States
Founded Date:
2009-01-01
Employees Number:
11-50
Funding Status:
IPO
Acquisitions Number:
1
Investors Number:
3
Total Funding:
33464587
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-07-19
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership